Beta-k-2C-B βk-2C-B 80mg Blister

€ 59,95

Beta-k-2C-B βk-2C-B 80mg Blister (βk-2C-B) is a phenethylamine-related research material supplied by Raw Lab Chems in a blister format for controlled analytical, forensic, and reference-oriented laboratory workflows. Batch-specific purity and supporting analytical documentation should be confirmed from the applicable product documentation where available.

For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.

SKU: CERT-S-13007 Category:
Description

Beta-k-2C-B βk-2C-B 80mg Blister

Product Overview

Beta-k-2C-B βk-2C-B 80mg Blister is a formulated laboratory research product containing the compound identified in the supplied information as Beta-k-2C-B or βk-2C-B. The source describes the material as a phenethylamine-related compound and the β-keto analogue of 2C-B, positioning it exclusively for controlled scientific, analytical, forensic, and reference-oriented research.

The blister format provides an individually packaged presentation that can be incorporated into laboratory inventory and sample-tracking workflows. The presence of a labeled unit strength describes the supplied product format and should not be interpreted as administration or human-use guidance.

Raw Lab Chems presents the material strictly within a Research Use Only framework. The supplied source does not provide a fixed numerical purity specification, instead stating that batch-specific purity information is available on the applicable Certificate of Analysis where available.

Chemical Identity & Classification

The supplied identifiers are Beta-k-2C-B and βk-2C-B. The source additionally describes the compound as the β-keto analogue of 2C-B and places it within the 2C phenethylamine family.

No systematic chemical name, CAS Registry Number, molecular formula, molecular weight, stereochemical designation, salt form, or counterion information was supplied. These specifications are therefore not inferred from the product name, from 2C-B, or from related phenethylamine compounds.

Researchers may consult PubChem for public chemical-reference information. Any database record considered for laboratory use should be independently matched to the exact identity and chemical form documented for the research sample.

The distinction between Beta-k-2C-B and structurally related compounds is important for analytical work. Describing the compound as a β-keto analogue establishes a structural relationship but does not make analytical specifications for 2C-B or another related compound directly transferable to this material.

Chemical & Physical Characteristics

The supplied material is described as a blister-pack unit intended for controlled laboratory handling. No verified description of the material inside the blister, including color, physical state, excipient composition, dimensions, texture, or other formulation-specific characteristics, was supplied.

No quantitative solubility data, melting point, density, hygroscopicity, chromatographic retention information, or validated stability measurements were provided. These properties are therefore not inferred from 2C-B or other compounds within the broader phenethylamine research category.

The source recommends storage in a cool, dry, dark environment while keeping the blister packaging intact. No specific storage temperature, validated shelf life, degradation profile, temperature-excursion study, or formal stability dataset accompanied this recommendation.

Researchers should consequently treat these storage statements as source-provided handling guidance rather than independently validated stability specifications.

Because the product is a formulated blister presentation, laboratories should distinguish characteristics of the underlying compound from those of the complete formulation, including any unspecified components.

Purity & Analytical Verification

The supplied information does not provide a fixed numerical purity specification for Beta-k-2C-B 80mg Blister. Instead, it states that batch-specific purity information is available on the applicable Certificate of Analysis where applicable.

Accordingly, no ≥98%, ≥99%, or other numerical purity value is assigned without supporting batch-specific documentation. This avoids presenting a general catalog expectation as though it were an analytical result established for a particular lot.

The source references COA availability, laboratory verification, identity confirmation, and documented purity as quality-assurance measures. No actual Certificate of Analysis, chromatogram, mass spectrum, NMR spectrum, independent laboratory report, or other batch-specific analytical result accompanied the supplied information.

These quality statements are therefore retained as source-provided information rather than independently verified analytical evidence.

Appropriately validated chromatographic, spectrometric, or spectroscopic methods may be relevant to identity, purity, impurity-profile, and comparative characterization research. Method selection depends on the exact chemical form, formulation, analytical objective, reference standards, instrumentation, and validation requirements.

Quality Control & Batch Integrity

The supplied source describes COA availability, lot or batch tracking, laboratory verification, and laboratory-grade documentation where applicable. Such documentation can contribute to traceability when it is specifically linked to the batch being examined.

No Certificate of Analysis, independent laboratory report, batch record, quality-system certification, or underlying analytical dataset accompanied the source. These statements should therefore not be interpreted as independently verified certifications or guarantees.

For reproducible analytical and forensic work, laboratory records should connect observations to the exact research sample examined. Useful records may include product identity, alternative identifiers, lot or batch number, supplier, receipt information, storage history, applicable documentation, and analytical observations.

Researchers should also distinguish general catalog information from batch-specific analytical evidence. Findings associated with one lot or formulation should not automatically be transferred to another without appropriate supporting documentation.

Safety, Handling & Laboratory Precautions

Beta-k-2C-B should be handled exclusively by appropriately trained personnel in a controlled laboratory environment. Institutional risk assessment should determine suitable personal protective equipment, containment, ventilation, access restrictions, contamination controls, and waste-management procedures.

The supplied source references receptor-interaction profiling and forensic research as potential laboratory contexts. These references describe areas of experimental investigation and do not establish safety or suitability for human or veterinary exposure.

Researchers should consult an applicable Safety Data Sheet or institutional chemical-safety documentation for the exact material when establishing procedures for accidental exposure, spills, environmental release, contamination control, waste collection, and disposal.

The material should remain secured against unauthorized access and separated from food, beverages, children, pets, and non-research environments. The blister presentation should not be interpreted as indicating a pharmaceutical, clinical, or consumer application.

Packaging, Labeling & Storage

The supplied product format is a blister-pack unit. The source recommends keeping the blister packaging intact and storing the material in a cool, dry, dark location.

No validated packaging specification, barrier-performance dataset, container-closure study, transportation study, or environmental-stability report was supplied. Statements concerning packaging integrity and environmental protection therefore remain source-provided handling information rather than independently established technical performance.

Laboratory labels and inventory records should preserve the Beta-k-2C-B and βk-2C-B identifiers, together with lot or batch information where available, receipt information, and storage history.

The source also describes discreet, stable worldwide shipment. No supporting shipping, carrier, or packaging-performance documentation was supplied, so those statements are not represented here as independently verified fulfillment guarantees.

Intended Research Use & Market Positioning

Beta-k-2C-B is positioned exclusively for controlled in-vitro, analytical, forensic, and reference-oriented research. The supplied research contexts include compound characterization, receptor-interaction profiling, forensic reference work, and analytical method development.

References to receptor interactions describe laboratory research subjects rather than effects or outcomes in humans. This description does not provide experiential, behavioral, therapeutic, physiological, or recreational information.

For comparative catalog research involving another related research material, Raw Lab Chems lists βOH-2C-B Pellets. Researchers examining a different phenethylamine-related material can separately review Promal Methallylescaline Blister. These products represent distinct research materials and should not be treated as chemically or analytically interchangeable.

The Raw Lab Chems Beta-k-2C-B research listing provides the supplied catalog reference for the blister-format material described here.

No medical, therapeutic, diagnostic, veterinary, recreational, experiential, psychoactive, or other consumptive application is represented by this description.

Ordering, Availability & Fulfillment

Institutional procurement should begin with confirmation of the exact chemical identity, chemical form, formulation, batch documentation, institutional authorization, and jurisdiction-specific requirements applicable to the intended research.

The supplied source describes worldwide shipment and packaging practices intended to maintain material integrity during transit. No current inventory record, shipping schedule, carrier documentation, geographic-availability record, or other fulfillment evidence accompanied the supplied information.

No independent claims are therefore made concerning current inventory, dispatch schedules, delivery times, courier services, tracking availability, customs processing, geographic availability, or payment methods.

Researchers and institutions remain responsible for determining whether acquisition, possession, import, export, transfer, storage, and investigation of the material are permitted and appropriately authorized within their jurisdiction and institutional framework.

Legal & Regulatory Disclaimer

For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.

Beta-k-2C-B and βk-2C-B are presented exclusively as laboratory research materials. Regulatory treatment may differ according to jurisdiction, exact chemical form, formulation, intended research activity, institutional policy, and applicable controlled-substance, analogue, chemical-control, forensic, medicines, or research frameworks.

Researchers and institutions are responsible for determining and complying with requirements governing acquisition, possession, licensing, import, export, transfer, storage, security, research, environmental handling, and disposal.

A research-use designation does not establish universal legality, medical approval, or exemption from controlled-substance, analogue, medicines, institutional, or other applicable requirements.

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “Beta-k-2C-B βk-2C-B 80mg Blister”
Shipping & Delivery